Guided Therapeutics, Inc. (GTHP)
USD 0.08
(0.0%)
USD 0.08
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.47 Million USD | -12.39% |
| 2022 | 6.24 Million USD | -16.51% |
| 2021 | 7.48 Million USD | -38.67% |
| 2020 | 12.2 Million USD | -32.62% |
| 2019 | 18.11 Million USD | 12.8% |
| 2018 | 16.06 Million USD | -19.26% |
| 2017 | 19.89 Million USD | 84.89% |
| 2016 | 10.75 Million USD | 32.41% |
| 2015 | 8.12 Million USD | 8.39% |
| 2014 | 7.49 Million USD | 118.99% |
| 2013 | 3.42 Million USD | 45.97% |
| 2012 | 2.34 Million USD | -14.2% |
| 2011 | 2.73 Million USD | -2.46% |
| 2010 | 2.8 Million USD | -78.05% |
| 2009 | 12.76 Million USD | 49.85% |
| 2008 | 8.51 Million USD | 44.23% |
| 2007 | 5.9 Million USD | -53.06% |
| 2006 | 12.58 Million USD | 58.92% |
| 2005 | 7.91 Million USD | 21.8% |
| 2004 | 6.5 Million USD | -21.66% |
| 2003 | 8.29 Million USD | 25.03% |
| 2002 | 6.63 Million USD | -25.88% |
| 2001 | 8.95 Million USD | 236.2% |
| 2000 | 2.66 Million USD | -63.01% |
| 1999 | 7.2 Million USD | 700.0% |
| 1998 | 900 Thousand USD | -40.0% |
| 1997 | 1.5 Million USD | 36.36% |
| 1996 | 1.1 Million USD | 39.24% |
| 1995 | 790 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 5.5 Million USD | 0.57% |
| 2024 Q2 | 5.91 Million USD | 7.48% |
| 2023 FY | 5.47 Million USD | -12.39% |
| 2023 Q1 | 5.74 Million USD | -8.03% |
| 2023 Q2 | 5.66 Million USD | -1.46% |
| 2023 Q3 | 5.52 Million USD | -2.4% |
| 2023 Q4 | 5.47 Million USD | -0.94% |
| 2022 Q1 | 7.17 Million USD | -4.13% |
| 2022 FY | 6.24 Million USD | -16.51% |
| 2022 Q2 | 7.26 Million USD | 1.3% |
| 2022 Q3 | 6.52 Million USD | -10.28% |
| 2022 Q4 | 6.24 Million USD | -4.19% |
| 2021 Q2 | 7.39 Million USD | 2.9% |
| 2021 Q1 | 7.18 Million USD | -41.15% |
| 2021 Q3 | 6.82 Million USD | -7.7% |
| 2021 FY | 7.48 Million USD | -38.67% |
| 2021 Q4 | 7.48 Million USD | 9.72% |
| 2020 FY | 12.2 Million USD | -32.62% |
| 2020 Q1 | 11.7 Million USD | -35.36% |
| 2020 Q2 | 17.36 Million USD | 48.3% |
| 2020 Q3 | 15.12 Million USD | -12.93% |
| 2020 Q4 | 12.2 Million USD | -19.28% |
| 2019 Q1 | 16.41 Million USD | 2.2% |
| 2019 Q4 | 18.11 Million USD | -1.32% |
| 2019 Q3 | 18.35 Million USD | -2.58% |
| 2019 Q2 | 18.84 Million USD | 14.82% |
| 2019 FY | 18.11 Million USD | 12.8% |
| 2018 FY | 16.06 Million USD | -19.26% |
| 2018 Q3 | 14.66 Million USD | 0.17% |
| 2018 Q1 | 18.46 Million USD | -7.17% |
| 2018 Q2 | 14.63 Million USD | -20.74% |
| 2018 Q4 | 16.06 Million USD | 9.54% |
| 2017 Q4 | 19.89 Million USD | 50.12% |
| 2017 FY | 19.89 Million USD | 84.89% |
| 2017 Q2 | 11.85 Million USD | 12.43% |
| 2017 Q3 | 13.25 Million USD | 11.77% |
| 2017 Q1 | 10.54 Million USD | -1.99% |
| 2016 Q4 | 10.75 Million USD | 14.81% |
| 2016 Q2 | 9.44 Million USD | 20.89% |
| 2016 Q3 | 9.37 Million USD | -0.84% |
| 2016 FY | 10.75 Million USD | 32.41% |
| 2016 Q1 | 7.81 Million USD | -3.8% |
| 2015 Q1 | 7.57 Million USD | 1.09% |
| 2015 Q2 | 6.77 Million USD | -10.61% |
| 2015 Q3 | 6.25 Million USD | -7.74% |
| 2015 FY | 8.12 Million USD | 8.39% |
| 2015 Q4 | 8.12 Million USD | 30.0% |
| 2014 Q4 | 7.49 Million USD | -2.23% |
| 2014 FY | 7.49 Million USD | 118.99% |
| 2014 Q2 | 6.31 Million USD | 63.37% |
| 2014 Q1 | 3.86 Million USD | 12.94% |
| 2014 Q3 | 7.66 Million USD | 21.39% |
| 2013 Q2 | 2.65 Million USD | 53.8% |
| 2013 FY | 3.42 Million USD | 45.97% |
| 2013 Q3 | 2.4 Million USD | -9.09% |
| 2013 Q1 | 1.72 Million USD | -26.52% |
| 2013 Q4 | 3.42 Million USD | 42.09% |
| 2012 Q1 | 2.17 Million USD | -20.34% |
| 2012 Q2 | 3.08 Million USD | 41.48% |
| 2012 Q4 | 2.34 Million USD | -11.41% |
| 2012 FY | 2.34 Million USD | -14.2% |
| 2012 Q3 | 2.64 Million USD | -14.06% |
| 2011 FY | 2.73 Million USD | -2.46% |
| 2011 Q4 | 2.73 Million USD | -45.37% |
| 2011 Q3 | 5 Million USD | 72.04% |
| 2011 Q2 | 2.9 Million USD | 23.22% |
| 2011 Q1 | 2.36 Million USD | -15.77% |
| 2010 FY | 2.8 Million USD | -78.05% |
| 2010 Q4 | 2.8 Million USD | -0.99% |
| 2010 Q3 | 2.83 Million USD | -8.21% |
| 2010 Q1 | 2.63 Million USD | -79.37% |
| 2010 Q2 | 3.08 Million USD | 17.09% |
| 2009 Q4 | 12.76 Million USD | 0.55% |
| 2009 FY | 12.76 Million USD | 49.85% |
| 2009 Q1 | 9.6 Million USD | 12.75% |
| 2009 Q2 | 10.86 Million USD | 13.14% |
| 2009 Q3 | 12.69 Million USD | 16.82% |
| 2008 Q3 | 8.99 Million USD | 14.25% |
| 2008 Q4 | 8.51 Million USD | -5.3% |
| 2008 FY | 8.51 Million USD | 44.23% |
| 2008 Q2 | 7.87 Million USD | 10.82% |
| 2008 Q1 | 7.1 Million USD | 20.28% |
| 2007 Q3 | 5.31 Million USD | 9.8% |
| 2007 Q4 | 5.9 Million USD | 11.18% |
| 2007 Q1 | 11.1 Million USD | -11.71% |
| 2007 Q2 | 4.83 Million USD | -56.45% |
| 2007 FY | 5.9 Million USD | -53.06% |
| 2006 Q3 | 11.74 Million USD | 10.81% |
| 2006 FY | 12.58 Million USD | 58.92% |
| 2006 Q1 | 9.68 Million USD | 22.29% |
| 2006 Q2 | 10.59 Million USD | 9.47% |
| 2006 Q4 | 12.58 Million USD | 7.13% |
| 2005 FY | 7.91 Million USD | 21.8% |
| 2005 Q4 | 7.91 Million USD | -12.27% |
| 2005 Q3 | 9.02 Million USD | 1.59% |
| 2005 Q2 | 8.88 Million USD | 27.59% |
| 2005 Q1 | 6.96 Million USD | 7.11% |
| 2004 Q2 | 6.24 Million USD | -19.99% |
| 2004 Q3 | 6.33 Million USD | 1.31% |
| 2004 Q4 | 6.5 Million USD | 2.69% |
| 2004 Q1 | 7.8 Million USD | -5.88% |
| 2004 FY | 6.5 Million USD | -21.66% |
| 2003 Q3 | 9.5 Million USD | 14.45% |
| 2003 Q1 | 8.59 Million USD | 29.52% |
| 2003 FY | 8.29 Million USD | 25.03% |
| 2003 Q4 | 8.29 Million USD | -12.68% |
| 2003 Q2 | 8.3 Million USD | -3.41% |
| 2002 Q2 | 7.03 Million USD | -11.65% |
| 2002 Q3 | 6.77 Million USD | -3.71% |
| 2002 Q1 | 7.95 Million USD | -11.1% |
| 2002 Q4 | 6.63 Million USD | -1.99% |
| 2002 FY | 6.63 Million USD | -25.88% |
| 2001 Q2 | 8.63 Million USD | 9.27% |
| 2001 FY | 8.95 Million USD | 236.2% |
| 2001 Q4 | 8.95 Million USD | 12.11% |
| 2001 Q3 | 7.98 Million USD | -7.54% |
| 2001 Q1 | 7.9 Million USD | 196.81% |
| 2000 Q1 | 7.07 Million USD | -1.71% |
| 2000 FY | 2.66 Million USD | -63.01% |
| 2000 Q4 | 2.66 Million USD | -65.09% |
| 2000 Q3 | 7.62 Million USD | 249.63% |
| 2000 Q2 | 2.18 Million USD | -69.17% |
| 1999 Q4 | 7.2 Million USD | 227.27% |
| 1999 Q3 | 2.2 Million USD | 100.0% |
| 1999 Q2 | 1.1 Million USD | -8.33% |
| 1999 Q1 | 1.2 Million USD | 33.33% |
| 1999 FY | 7.2 Million USD | 700.0% |
| 1998 FY | 900 Thousand USD | -40.0% |
| 1998 Q1 | 2.4 Million USD | 60.0% |
| 1998 Q2 | 1.2 Million USD | -50.0% |
| 1998 Q3 | 700 Thousand USD | -41.67% |
| 1998 Q4 | 900 Thousand USD | 28.57% |
| 1997 FY | 1.5 Million USD | 36.36% |
| 1997 Q2 | 1.9 Million USD | 35.71% |
| 1997 Q4 | 1.5 Million USD | -6.25% |
| 1997 Q3 | 1.6 Million USD | -15.79% |
| 1997 Q1 | 1.4 Million USD | 17.65% |
| 1996 FY | 1.1 Million USD | 39.24% |
| 1996 Q4 | 1.19 Million USD | 0.0% |
| 1995 FY | 790 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | 52.775% |
| BioElectronics Corporation | 16.62 Million USD | 67.063% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -763.565% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -707.98% |
| Polarean Imaging plc | 2.58 Million USD | -112.165% |
| AVITA Medical, Inc. | 19.86 Million USD | 72.44% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -158.499% |
| Össur hf. | 688.8 Million USD | 99.205% |
| Zecotek Photonics Inc. | 5.86 Million USD | 6.707% |
| QHSLab, Inc. | 2.05 Million USD | -166.158% |
| Wellstar International, Inc. | 55.99 Million USD | 90.222% |
| Össur hf. | 688.8 Million USD | 99.205% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 65.953% |
| Escalon Medical Corp. | 2.94 Million USD | -85.698% |
| Aurora Spine Corporation | 6.65 Million USD | 17.713% |
| BrainsWay Ltd. | 15.31 Million USD | 64.248% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 8.942% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 88.057% |
| Vivos Inc. | 245 Thousand USD | -2134.657% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.78% |
| Kelyniam Global, Inc. | 1.01 Million USD | -440.509% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -1886.474% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -123.487% |
| Nanomix Corporation | 14.81 Million USD | 63.044% |
| Theraclion SA | 13.01 Million EUR | 57.938% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -6.846% |
| Positron Corporation | 2.02 Million USD | -170.237% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -51.194% |
| Lombard Medical, Inc. | 53.79 Million USD | 89.822% |
| ALR Technologies Inc. | 24.5 Million USD | 77.658% |
| Stratec SE | 271.97 Million USD | 97.987% |
| Vycor Medical, Inc. | 4.31 Million USD | -26.801% |
| Heart Tronics, Inc. | 1.09 Million USD | -400.096% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -132.111% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 0.029% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 91.653% |
| VMS Rehab Systems, Inc. | 201.36 USD | -2718910.727% |
| Ingen Technologies, Inc. | 5.7 Million USD | 4.108% |
| Odyssey Group International, Inc. | 6.61 Million USD | 17.193% |
| United American Healthcare Corporation | 119 Thousand USD | -4500.84% |
| ECGI Holdings, Inc. | 11.94 Million USD | 54.147% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -313.525% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -278.542% |
| Urologix, Inc. | 12.64 Million USD | 56.699% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -1.463% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 35.455% |
| SS Innovations International, Inc. | 11.18 Million USD | 51.033% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -942.089% |
| Smith & Nephew plc | 4.76 Billion USD | 99.885% |
| NIOX Group Plc | 9.8 Million USD | 44.145% |
| Fuse Medical, Inc. | 15.11 Million USD | 63.766% |
| Broncus Holding Corporation | 10.43 Million USD | 47.518% |
| Brain Scientific Inc. | 7.42 Million USD | 26.277% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 83.803% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -589.476% |